PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)
PROCEPT BioRobotics' (PRCT) quarterly Preferred Stock Liabilities came in at $328.6 million in Q2 2021, up 34.74% quarter-over-quarter from $243.9 million in Q1 2021.
Powered by 
Analysis
PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Preferred Stock Liabilities for 2 consecutive years, with $328.6 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $328.6 million in Q2 2021; TTM through Jun 2021 was $328.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $243.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $328.6 million for Q2 2021 at PROCEPT BioRobotics, up from $243.9 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $328.6 million in Q2 2021 and troughed at $243.9 million in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 328.56 Mn |
| Mar 31, 2021 | 243.85 Mn |
| Dec 31, 2020 | 243.85 Mn |
| Sep 30, 2020 | 243.85 Mn |